Showing results (11-20 of 413) with videos related to
Sort By:
Pageof 42
Drug Safety|August 17, 2000
The value of reporting therapeutic ineffectiveness as an adverse drug reactionR H Meyboom, M Lindquist, A K Flygare, et al.European Journal of Respiratory Diseases|June 1, 1981
Intravenous use of rifampicinB S Nilsson, G BomanJournal of Bacteriology|April 1, 1983
Escherichia coli mutants with an altered sensitivity to cecropin DI Sidén, H G BomanJournal of Advanced Nursing|January 1, 1982
A descriptive study of pressure sores: the prevalence of pressure sores and the characteristics of patientsA C Ek, G BomanEuropean Journal of Clinical Pharmacology|June 13, 1975
Mechanism of the inhibitory effect of PAS granules on the absorption of rifampicin: adsorption of rifampicin by an excipient, bentoniteG Boman, P Lundgren, G StjernströmUpsala Journal of Medical Sciences|January 1, 1995
Effects of positive expiratory pressure (PEP), continuous positive airway pressure (CPAP) and hyperventilation in COPD patients with chronic hypercapneaM Herala, G Stålenheim, G BomanUpsala Journal of Medical Sciences|January 1, 1989
Transcutaneous CO2 monitoring in adults with sleep-related breathing disordersT Gislason, B Sandhagen, G BomanJournal of Bacteriology|February 1, 1975
Characterization of lipopolysaccharides from Escherichia coli K-12 mutantsH G Boman, D A MonnerJournal of Bacteriology|February 1, 1975
Blocking of bacteriophages phi W and phi 5 with lipopolysaccharides from Escherichia coli K-12 mutantsH G Boman, D A MonnerInfection and Immunity|August 1, 1977
Insect immunity. III. Purification and partial characterization of immune protein P5 from hemolymph of Hyalophora cecropia pupaeA E Pye, H G BomanPageof 42